MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$23,484K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts receivable
Proceeds from maturities of shor...
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Accrued rebates, returns and dis...
Net loss
Purchases of short-term investme...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Impairment of intangible assets
-
1,700
-
-
Loss on assertio therapeutics divestiture
-
0
0
-8,174
Net loss
-18,856
-11,927
11,445
-29,893
Depreciation and amortization
5,840
5,839
5,630
18,536
Amortization of debt issuance costs
125
122
120
233
Impairment of intangible assets
-
-
1,700
-
Accretion of interest income from short-term investments
-180
-49
-8
-36
Recurring fair value measurements of assets and liabilities
-30
167
302
-34
Payment of contingent consideration
-
450
-
-
Provisions for inventory
198
1,313
522
2,675
Stock-based compensation
725
97
1,067
2,290
Accounts receivable
-58,583
-21,197
80,217
6,970
Inventories
-912
670
-7,595
-2,753
Prepaid and other assets
1,698
4,896
-14,017
7,912
Accounts payable and other accrued liabilities
196
-9,955
-10,351
7,014
Accrued rebates, returns and discounts
-37,022
-31,170
44,649
9,583
Interest payable
0
-
-650
-
Net cash provided by (used in) operating activities
8,563
-29,968
-4,767
6,553
Assertio therapeutics divestiture
-
0
0
8,174
Proceeds from maturities of short-term investments
30,368
30,151
27,660
57,572
Purchases of short-term investments
15,258
28,452
31,472
59,273
Net cash provided by (used in) investing activities
15,110
1,699
-3,812
-9,875
Payments related to the vesting and settlement of equity awards
189
2
7
180
Net cash used in financing activities
-189
-2
-7
-180
Net increase (decrease) in cash and cash equivalents
23,484
-28,271
-8,586
-3,502
Cash and cash equivalents at beginning of year
10,229
38,500
50,588
-
Cash and cash equivalents at end of period
33,713
10,229
38,500
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of short-term...
$30,368K
Accounts receivable
-$58,583K
Depreciation and
amortization
$5,840K
Inventories
-$912K
Stock-based compensation
$725K
Provisions for inventory
$198K
Accounts payable and
other accrued...
$196K
Accretion of interest
income from short-term...
-$180K
Amortization of debt issuance
costs
$125K
Recurring fair value
measurements of assets and...
-$30K
Net cash provided by
(used in) investing...
$15,110K
Net cash provided by
(used in) operating...
$8,563K
Canceled cashflow
$15,258K
Canceled cashflow
$58,226K
Net increase
(decrease) in cash and cash...
$23,484K
Canceled cashflow
$189K
Purchases of short-term
investments
$15,258K
Accrued rebates,
returns and discounts
-$37,022K
Net loss
-$18,856K
Prepaid and other assets
$1,698K
something is missing
-$650K
Net cash used in
financing activities
-$189K
Payments related to the
vesting and settlement...
$189K
Buy us a coffee
Assertio Holdings, Inc. (ASRT)
Assertio Holdings, Inc. (ASRT)